Home > Boards > Canadian > Internet - E-Commerce > Cyberads, Inc. (CYAD)

News: $CYAD Celyad Announces Third Quarter 2019 Financial

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 55
Posts 6,971
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/2/2019 6:22:46 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/16/2019 4:19:46 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/12/2019 5:17:45 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/12/2019 5:15:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/10/2019 4:10:07 PM
Amended Report of Foreign Issuer (6-k/a) Edgar (US Regulatory) - 9/5/2019 4:07:41 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/4/2019 7:05:43 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/23/2019 7:54:42 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/9/2019 6:21:12 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/8/2019 7:23:43 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/8/2019 7:20:08 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/3/2019 6:23:43 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/15/2019 7:02:18 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 4/5/2019 5:19:34 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 4/3/2019 4:42:41 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/21/2019 12:58:17 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 3/11/2019 6:08:55 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/1/2019 4:21:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/7/2019 7:13:45 AM
whytestocks Member Level  Tuesday, 11/19/19 07:00:24 AM
Re: None
Post # of 125 
News: $CYAD Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

MONT-SAINT-GUIBERT, Belgium, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on its operational developments for the third quart...

Read the whole news CYAD - Celyad Announces Third Quarter 2019 Financial Results and Recent Business Highlights

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist